Epigenetic modifications and targeted therapy in pediatric acute myeloid leukemia
Acute myeloid leukemia (AML) is a hematological malignancy resulting from the genetic alterations and epigenetic dysregulations of the hematopoietic progenitor cells. One-third of children with AML remain at risk of relapse even though outcomes have improved in recent decades. Epigenetic dysregulati...
Main Authors: | Huan Xu, Yuxi Wen, Runming Jin, Hongbo Chen |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-09-01
|
Series: | Frontiers in Pediatrics |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fped.2022.975819/full |
Similar Items
-
Epigenetic Modifications in Pediatric Acute Lymphoblastic Leukemia
by: Michael James Burke, et al.
Published: (2014-05-01) -
The epigenetic landscape of innate immunity
by: Mariacristina De Luca, et al.
Published: (2017-03-01) -
Emerging Evidence of Epigenetic Modifications in Vascular Complication of Diabetes
by: Madhu Khullar, et al.
Published: (2017-09-01) -
The Prospective Application of Melatonin in Treating Epigenetic Dysfunctional Diseases
by: Seth Mikaye Monayo, et al.
Published: (2022-05-01) -
The Role of Epigenetic Modifications in Neurotoxicity Induced by Neonatal General Anesthesia
by: Lin-Hui Ma, et al.
Published: (2022-04-01)